MAIA Biotechnology
MAIA
MAIA
20 hedge funds and large institutions have $2.26M invested in MAIA Biotechnology in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
18% less capital invested
Capital invested by funds: $2.75M → $2.26M (-$493K)
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$125K | |
| 2 | +$80.4K | |
| 3 | +$31.3K | |
| 4 |
NW
Naviter Wealth
Little Rock,
Arkansas
|
+$18.5K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$12.9K |
Top Sellers
| 1 | -$77.3K | |
| 2 | -$18K | |
| 3 | -$6.41K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.64K |